NEW YORK (GenomeWeb) – Luminex reported after the close of the market Monday that its fourth quarter revenues rose 20 percent year over year, aided by 39 percent growth over the prior-year period for Nanosphere, a company it acquired in 2016.

For the three months ended Dec. 31, the firm reported revenues rose to $72.3 million from $60.4 million a year ago, beating analysts' consensus estimate of $70.9 million.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.